Ieq Capital, LLC Glycomimetics Inc Transaction History
Ieq Capital, LLC
- $8.04 Billion
- Q3 2024
A detailed history of Ieq Capital, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Ieq Capital, LLC holds 38,363 shares of GLYC stock, worth $16,112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,363
Previous 38,363
-0.0%
Holding current value
$16,112
Previous $10,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GLYC
# of Institutions
34Shares Held
17.8MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA9.54MShares$4.01 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$1.12 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$825,3470.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny781KShares$328,0620.0% of portfolio
-
Black Rock Inc. New York, NY723KShares$303,7370.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $22M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...